Aid organisations have expressed horror at the UK government’s decision to slash spending on overseas development in order to fund an increase in the defence budget. On 25 February UK prime minister ...

Institutions must value patient partners in research with fair and transparent compensation policies, or their commitments to equity will be hollow, write Amy Price and Dawn P Richards A conflict ...

Launer recalls a patient vignette in a government pamphlet about a patient called Sarah with sinus pain and hearing loss who is referred by a nurse practitioner for a CT scan. She uses the NHS app to ...

Mun-Keat Looi looks at what the social network Bluesky is and why #MedSky might be worth trying In a nutshell, it’s a social network that tries to recreate the “good old days” of Twitter before it was ...

Public health solutions to health misinformation need to recognise the complex, structural nature of the online information environment, write Tina D Purnat and Jocalyn Clark Health misinformation and ...

Peter was born in Cambridge and enjoyed an itinerant childhood because his father, Len, had a career in the Royal Air Force. Peter attended a number of schools across the country, spending the ...

Geoff was born in Manchester and after attending Manchester Grammar School went to Manchester Medical School. He completed house jobs at Manchester Royal Infirmary and Crumpsall Hospital, before ...

Two people in the US have been admitted to hospital with H5N1 avian flu, adding to concerns over the growing number of infections in cattle, poultry, wildlife, and humans worldwide. As of 24 February, ...

The doctor who took over as medical director of the NHS trust that employed Lucy Letby has told a public inquiry that her predecessor told her she should report the paediatricians who raised concerns ...

The Isle of Man is set to become the first place in the British Isles to legalise assisted dying, after a bill to allow terminally ill residents to end their life passed its final hurdle in the island ...

A London hospital is to investigate why over half of its patients with multiple sclerosis (MS) who switched from disease modifying therapy Tysabri (natalizumab) to biosimilar Tyruko have had to be ...

Evidence suggests no increased risk The use of glucagon-like peptide-1 (GLP-1) receptor agonists has surged in recent years, driven by their benefits in glucose control in type 2 diabetes, weight ...